LICP OpenIR

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
GP-14 protects against severe hypoxia-induced neuronal injury through the AKT and ERK pathways and its induced transcriptome profiling alteration 期刊论文
Toxicology and Applied Pharmacology, 2022, 期号: 448, 页码: 116092
Authors:  Ya-Nan Geng;  Ming Zhao;  Jun-Li Yang;  Xiang Cheng;  Ying Han;  Cheng-Bo Wang;  Xiu-Fang Jiang;  Ming Fan;  Ling-Ling Zhu
Adobe PDF(7671Kb)  |  Favorite  |  View/Download:38/0  |  Submit date:2022/11/30
Gypenoside-14 (GP-14)  Neuronal Damage  Hypoxia  Transcriptome Sequencing  Neuroprotection  
A bioactive gypenoside (GP-14) alleviates neuroinflammation and blood brain barrier (BBB) disruption by inhibiting the NF-κB signaling pathway in a mouse high-altitude cerebral edema (HACE) model 期刊论文
International Immunopharmacology, 2022, 期号: 107, 页码: 108675
Authors:  Ya-Nan Geng;  Jun-Li Yang;  Xiang Cheng;  Ying Han;  Feng Yan;  Cheng-Bo Wang;  Xiu-Fang Jiang;  Xian-Hua Meng;  Ming Fan;  Ming Zhao;  Ling-Ling Zhu
Adobe PDF(8858Kb)  |  Favorite  |  View/Download:36/0  |  Submit date:2022/11/30
Gypenoside  Neuroinflammation  Blood brain barrier  High altitude cerebral edema  NF-κB signaling pathway